Figure 5 | Scientific Reports

Figure 5

From: Rhoifolin from Plumula Nelumbinis exhibits anti-cancer effects in pancreatic cancer via AKT/JNK signaling pathways

Figure 5

AKT activator or JNK inhibitor could reverse the enhanced antioxidant capacity of Rhoifolin in pancreatic cancer cells. Rhoifolin-treated PANC-1 and ASPC-1 cells were also addressed with AKT activator (SC79) or JNK inhibitor (SP600125). (A) ROS level was assessed using DCFH-DA in ROS examination kit. (B) The positive rate of ROS in (A) was quantified. (C) The antioxidant capacity was evaluated using the ABTS kit. SOD (D), GPx (E), and catalase (F) levels were monitored by applying the corresponding kits.

Back to article page